Skip to main content

Security report for amgen.cz

Amgen · Healthcare · Czech Republic

Low risk. 2 critical or high findings in Email security and SSL/TLS.

Security score

82/100

Risk levelLow

0–100, higher is better. How it is calculated

Amgen Česká republika is the Czech branch of Amgen, a leading global biotechnology company focused on innovative medicines for serious illnesses. The website presents a professional and well-structured digital presence targeting patients, healthcare professionals, and stakeholders in the Czech Republic. The content emphasizes Amgen's commitment to science, innovation, and patient care. Technically, the site employs modern video streaming technologies (VideoJS, Brightcove), Google Tag Manager for analytics, and Cookiebot for GDPR-compliant cookie consent management. Security posture is solid with HTTPS enforced and a Content Security Policy in place, though additional security headers could enhance protection. The absence of WHOIS data and lack of visible contact information slightly reduce business credibility but do not detract significantly from the overall trustworthiness. Privacy compliance is strong, with clear cookie consent mechanisms and GDPR adherence. Strategic recommendations include enhancing security headers, publishing incident response and vulnerability disclosure policies, and improving transparency with contact details.

Scanned

NIS2 and GDPR posture

GDPR outside view
100/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching amgen.cz

This scan found 16 issues across 5 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
77
Security headers
80
Email security
60
DNS health
75
Network security
100
GDPR outside view
100
Average
82

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention amgen.cz, from OffSeq Breach.

No leaked records found

Breach holds no records for amgen.cz right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Amgen operates in the healthcare and biotechnology sector, delivering innovative pharmaceutical products. The Czech website reflects a mature enterprise-level digital footprint consistent with a global brand. The business model centers on research-driven drug development and patient-focused solutions. Market positioning is strong, leveraging Amgen's global reputation. The site lacks explicit business contact details and WHOIS transparency, which could be improved to support trust and customer engagement. The use of advanced video and analytics technologies indicates a commitment to digital maturity and user engagement. No direct evidence of partnerships or subsidiaries was found in the content provided.

Security posture

The website demonstrates a good security baseline with HTTPS and a Content Security Policy. However, it lacks other common security headers such as X-Frame-Options, X-XSS-Protection, and Strict-Transport-Security, which are recommended to mitigate common web vulnerabilities. No exposed sensitive data or vulnerable libraries were detected in the provided content. The cookie consent mechanism is robust, supporting GDPR compliance. There is no evidence of a published security policy, incident response plan, or vulnerability disclosure program, which are important for transparency and trust. Overall, the security posture is good but could be improved with additional policies and headers.

Recommendations

  1. Implement additional security headers including X-Frame-Options, X-XSS-Protection, and Strict-Transport-Security.
  2. Publish a security policy and incident response plan accessible on the website.
  3. Create and publish a vulnerability disclosure policy and security.txt file.
  4. Add clear and verified contact information including company emails and phone numbers.
  5. Enhance WHOIS transparency or provide justification for privacy protection to improve trust.

Contact details published on the site

Addresses
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Amgen
Description
Amgen je společnost založená na hodnotách, na vědeckém poznání a inovacích. Zjistěte více otom, jak se nám daří přeměňovat nové myšlenky a objevy na léky pro pacienty se závážnými onemocněními.
Key services
Development and provision of innovative medicines
Content quality
good
Branding
consistent

Technology

Stack
VideoJS, Brightcove Player, Google Tag Manager, Cookiebot
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Content Security Policy present
  • Cookie consent implemented

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Cookiebot
Marketing tools
Cookiebot
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. WHOIS data is unavailable or not publicly disclosed, which is unusual for a corporate domain.
  3. Strong GDPR and cookie consent compliance observed.
  4. No explicit contact emails or phone numbers found in the HTML content provided.
  5. No visible forms detected in the provided HTML snippet.
  6. Use of modern video player technology and analytics tools.
  7. Security headers are minimal but present; HTTPS enforced.
  8. No security.txt or vulnerability disclosure policy found.
  9. No incident response or security policy pages detected.
Technical notes

Notes

The website uses modern web technologies including VideoJS and Brightcove for video content delivery, Google Tag Manager for analytics, and Cookiebot for cookie consent management. The HTML structure is valid and includes appropriate meta tags for SEO and social media sharing (Open Graph, Twitter cards). Performance appears moderate with prefetching of images and asynchronous loading of scripts. Mobile optimization is good with responsive design elements. Accessibility features are basic but present. The site lacks a detected CMS or hosting provider information. Overall, the technical implementation supports a professional and user-friendly experience but could benefit from enhanced accessibility and security features.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with amgen.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review amgen.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.